Arroyo Armando, Pernasetti Flavia, Vasilyev Vyacheslav V, Amato Paula, Yen Samuel S C, Mellon Pamela L
Department of Reproductive Medicine, University of California, San Diego, La Jolla, CA 92093-0674, USA.
Clin Endocrinol (Oxf). 2002 Aug;57(2):283-91. doi: 10.1046/j.1365-2265.2002.01550.x.
We report a 28-year-old-female who presented with primary amenorrhoea, absence of puberty, obesity and normal stature. The subject was clearly short as a child, with a height more than 2 SD below normal until the age of 15 years. The pubertal growth spurt failed to develop. She continued growing at a prepubertal rate until growth ceased at the age of 20 years, reaching her final adult height of 157 cm (SDS -0.86) without hormonal treatment. A combined pituitary hormone stimulation test of anterior pituitary function showed deficiencies of GH, LH and FSH, and low normal serum levels of TSH and PRL. Magnetic resonance imaging revealed a hypoplastic pituitary with markedly reduced pituitary height. In addition, a whole body dual energy X-ray absorptiometry scan showed high levels of body fat (54%). Combined pituitary hormone deficiencies with a hypoplastic pituitary suggested the diagnosis of a Prophet of Pit-1 (PROP1) gene mutation. Normal stature in this case, however, confounded this diagnosis. Sequencing of PROP1 revealed homozygosity for a single base-pair substitution (C to T), resulting in the replacement of an Arg by a Cys at codon 120 (R120C) in the third helix of the homeodomain of the Prop-1 protein. To our knowledge, this is the first report of a patient with a mutation in the PROP1 gene that attained normal height without hormonal treatment, indicating a new variability in the PROP1 phenotype, with important implications for the diagnosis of these patients. We suggest that this can be explained by (i) the presence of low levels of GH in the circulation during childhood and adolescence; (ii) the lack of circulating oestrogen delaying epiphyseal fusion, resulting in growth beyond the period of normal growth; and (iii) fusion of the epiphyseal plates, possibly as a result of circulating oestrogens originating from peripheral conversion of androgens by adipose tissue.
我们报告了一名28岁女性,她表现为原发性闭经、青春期未发育、肥胖且身材正常。该患者幼时明显矮小,直到15岁时身高比正常低超过2个标准差。青春期生长突增未能出现。她以青春期前的速度持续生长,直到20岁停止生长,在未接受激素治疗的情况下达到最终成人身高157厘米(标准差分值-0.86)。垂体前叶功能的联合垂体激素刺激试验显示生长激素(GH)、促黄体生成素(LH)和促卵泡生成素(FSH)缺乏,促甲状腺激素(TSH)和催乳素(PRL)血清水平处于正常低限。磁共振成像显示垂体发育不全,垂体高度明显降低。此外,全身双能X线吸收法扫描显示体脂水平较高(54%)。联合垂体激素缺乏伴垂体发育不全提示诊断为垂体特异性转录因子1(PROP1)基因突变。然而,该病例中正常的身材使这一诊断变得复杂。PROP1基因测序显示存在一个单碱基对替换(C突变为T)的纯合子,导致Prop-1蛋白同源结构域第三螺旋中第120位密码子处的精氨酸被半胱氨酸取代(R120C)。据我们所知,这是首例未经激素治疗而达到正常身高的PROP1基因突变患者的报告,表明PROP1表型存在新的变异性,对这些患者的诊断具有重要意义。我们认为这可以通过以下几点来解释:(i)儿童期和青春期循环中生长激素水平较低;(ii)缺乏循环雌激素延迟骨骺融合,导致生长超过正常生长时期;(iii)骨骺板融合,可能是由于脂肪组织将雄激素外周转化产生的循环雌激素所致。